Antiviral humoral immunity as biomarker and effector in oncolytic adenovirus TILT-123 therapy.

Arias V, Clubb JH, Kudling TV, Jirovec E, Pakola SA, Haybout L, Quixabeira DCA, van der Heijden M, Ojala N, Grönberg-Vähä-Koskela S, Raatikainen S, Chisamore MJ, Jalkanen K, Alanko T, Kemppainen J, Hellesuo M, Färkkilä A, Block MS, Monberg TJ, Svane IM, Mäenpää J, Sorsa S, Kistler C, Manuel Dos Santos J, Kanerva A, Hemminki O, Cervera-Carrascon V, Hemminki A

Open source

DOI: 10.1136/jitc-2026-016430
Published: 2026 Nov 4
Container: Journal for immunotherapy of cancer
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/jitc-2026-016430,
  title = {Antiviral humoral immunity as biomarker and effector in oncolytic adenovirus TILT-123 therapy.},
  author = {Arias V and Clubb JH and Kudling TV and Jirovec E and Pakola SA and Haybout L and Quixabeira DCA and van der Heijden M and Ojala N and Grönberg-Vähä-Koskela S and Raatikainen S and Chisamore MJ and Jalkanen K and Alanko T and Kemppainen J and Hellesuo M and Färkkilä A and Block MS and Monberg TJ and Svane IM and Mäenpää J and Sorsa S and Kistler C and Manuel Dos Santos J and Kanerva A and Hemminki O and Cervera-Carrascon V and Hemminki A},
  year = {2026},
  journal = {Journal for immunotherapy of cancer},
  doi = {10.1136/jitc-2026-016430},
  url = {https://doi.org/10.1136/jitc-2026-016430}
}

RIS

TY  - JOUR
TI  - Antiviral humoral immunity as biomarker and effector in oncolytic adenovirus TILT-123 therapy.
AU  - Arias V
AU  - Clubb JH
AU  - Kudling TV
AU  - Jirovec E
AU  - Pakola SA
AU  - Haybout L
AU  - Quixabeira DCA
AU  - van der Heijden M
AU  - Ojala N
AU  - Grönberg-Vähä-Koskela S
AU  - Raatikainen S
AU  - Chisamore MJ
AU  - Jalkanen K
AU  - Alanko T
AU  - Kemppainen J
AU  - Hellesuo M
AU  - Färkkilä A
AU  - Block MS
AU  - Monberg TJ
AU  - Svane IM
AU  - Mäenpää J
AU  - Sorsa S
AU  - Kistler C
AU  - Manuel Dos Santos J
AU  - Kanerva A
AU  - Hemminki O
AU  - Cervera-Carrascon V
AU  - Hemminki A
PY  - 2026
JO  - Journal for immunotherapy of cancer
DO  - 10.1136/jitc-2026-016430
UR  - https://doi.org/10.1136/jitc-2026-016430
ER  -

APA

V, A., JH, C., TV, K., E, J., SA, P., L, H., DCA, Q., M, V. D. H., N, O., S, G., S, R., MJ, C., K, J., T, A., J, K., M, H., A, F., MS, B., TJ, M., IM, S., J, M., S, S., C, K., J, M. D. S., A, K., O, H., V, C., & A, H. (2026). Antiviral humoral immunity as biomarker and effector in oncolytic adenovirus TILT-123 therapy.. Journal for immunotherapy of cancer. https://doi.org/10.1136/jitc-2026-016430

Source records

pubmed · retrieved 2026-11-10T11:01:10.497Z
doaj · retrieved 2026-11-10T11:01:10.484Z